FUNDING WILL ACCELERATE THE PHASE 0 NEURO-ONCOLOGY CLINICAL TRIAL PROGRAM BY SUPPORTING ESSENTIAL INFRASTRUCTURE, INCLUDING BASIC AND CLINICAL SCIENCE INVESTIGATORS, RESEARCH NURSES, BIOSTATISTICIANS AND A PROGRAM MANAGER. THIS PHASE 0 PROGRAM IS THE FIRST SUCH PROGRAMMATIC EFFORT FOR GLIOBLASTOMA PATIENTS WORLDWIDE.